Rhumbline Advisers Pet Iq, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Pet Iq, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 40,959 shares of PETQ stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,959

Previous 43,118 5.01%

Holding current value

$1.27 Million

Previous $951,000 32.49%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$20.57 - $30.79 $44,410 - $66,475	-2,159 Reduced 5.01%	40,959 $1.26 Million
Q2 2024 Aug 01, 2024	BUY	$15.93 - $22.26 $83,106 - $116,130	5,217 Added 13.76%	43,118 $951,000
Q1 2024 May 09, 2024	BUY	$15.55 - $19.42 $17,291 - $21,595	1,112 Added 3.02%	37,901 $692,000
Q4 2023 Feb 08, 2024	SELL	$17.18 - $22.38 $120 - $156	-7 Reduced 0.02%	36,789 $726,000
Q3 2023 Nov 09, 2023	BUY	$15.0 - $20.71 $13,140 - $18,141	876 Added 2.44%	36,796 $724,000
Q2 2023 Aug 08, 2023	SELL	$10.84 - $15.43 $10,764 - $15,321	-993 Reduced 2.69%	35,920 $544,000
Q1 2023 May 11, 2023	BUY	$9.32 - $12.58 $16,766 - $22,631	1,799 Added 5.12%	36,913 $422,000
Q4 2022 Feb 14, 2023	BUY	$6.82 - $12.07 $2,864 - $5,069	420 Added 1.21%	35,114 $324,000
Q3 2022 Nov 10, 2022	BUY	$6.9 - $18.16 $15,173 - $39,933	2,199 Added 6.77%	34,694 $239,000
Q2 2022 Aug 11, 2022	BUY	$14.09 - $25.12 $81,862 - $145,947	5,810 Added 21.77%	32,495 $546,000
Q1 2022 May 12, 2022	BUY	$17.92 - $24.4 $3,315 - $4,514	185 Added 0.7%	26,685 $651,000
Q4 2021 Feb 10, 2022	SELL	$19.97 - $25.91 $9,266 - $12,022	-464 Reduced 1.72%	26,500 $602,000
Q3 2021 Nov 12, 2021	BUY	$23.99 - $38.59 $29,987 - $48,237	1,250 Added 4.86%	26,964 $673,000
Q2 2021 Aug 05, 2021	BUY	$34.94 - $45.35 $57,860 - $75,099	1,656 Added 6.88%	25,714 $993,000
Q1 2021 May 06, 2021	SELL	$32.6 - $37.82 $56,887 - $65,995	-1,745 Reduced 6.76%	24,058 $848,000
Q4 2020 Feb 10, 2021	BUY	$24.99 - $38.45 $41,458 - $63,788	1,659 Added 6.87%	25,803 $992,000
Q3 2020 Nov 12, 2020	SELL	$29.04 - $37.49 $157,396 - $203,195	-5,420 Reduced 18.33%	24,144 $795,000
Q2 2020 Aug 13, 2020	BUY	$20.16 - $34.84 $65,903 - $113,891	3,269 Added 12.43%	29,564 $1.03 Million
Q1 2020 May 06, 2020	BUY	$16.59 - $34.94 $16,755 - $35,289	1,010 Added 3.99%	26,295 $611,000
Q4 2019 Feb 05, 2020	BUY	$22.24 - $27.56 $37,318 - $46,245	1,678 Added 7.11%	25,285 $633,000
Q3 2019 Oct 23, 2019	BUY	$25.56 - $36.1 $6,313 - $8,916	247 Added 1.06%	23,607 $644,000
Q2 2019 Aug 14, 2019	BUY	$24.79 - $32.96 $87,260 - $116,019	3,520 Added 17.74%	23,360 $770,000
Q1 2019 May 01, 2019	SELL	$23.31 - $31.41 $9,300 - $12,532	-399 Reduced 1.97%	19,840 $623,000
Q4 2018 Jan 31, 2019	BUY	$21.6 - $37.49 $243,259 - $422,212	11,262 Added 125.45%	20,239 $475,000
Q3 2018 Nov 07, 2018	SELL	$25.67 - $42.36 $6,802 - $11,225	-265 Reduced 2.87%	8,977 $353,000
Q2 2018 Aug 06, 2018	BUY	$17.91 - $26.86 $165,524 - $248,240	9,242 New	9,242 $248,000

Others Institutions Holding PETQ

# of Institutions

189

Shares Held

30M

Call Options Held

81K

Put Options Held

113K

View Full List

About PetIQ, Inc.

Ticker PETQ
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,312,800
Market Cap $908M
Description
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...

More about PETQ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Pet Iq, Inc. Transaction History